Cargando…
β-adrenergic receptor inhibition enhances oncolytic herpes virus propagation through STAT3 activation in gastric cancer
BACKGROUND: Oncolytic viruses (OVs) are considered a promising therapeutic alternative for cancer. However, OVs could activate the host innate immunity, then impair the viral propagation in tumor cells. In this study, we explored the effect of propranolol, a non-selective β-blocker, on the antitumor...
Autores principales: | Hu, Jiali, Lu, Ruitao, Zhang, Yu, Li, Wei, Hu, Qian, Chen, Cuiyu, Liu, Zhaoqian, Zhang, Wei, Chen, Ling, Xu, Ran, Luo, Jia, McLeod, Howard L., He, Yijing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454049/ https://www.ncbi.nlm.nih.gov/pubmed/34544479 http://dx.doi.org/10.1186/s13578-021-00687-1 |
Ejemplares similares
-
β-Adrenergic Receptor Inhibitor and Oncolytic Herpesvirus Combination Therapy Shows Enhanced Antitumoral and Antiangiogenic Effects on Colorectal Cancer
por: Hu, Jiali, et al.
Publicado: (2021) -
Clinical Use of Propranolol Reduces Biomarkers of Proliferation in Gastric Cancer
por: Hu, Qian, et al.
Publicado: (2021) -
Propranolol suppresses bladder cancer by manipulating intracellular pH via NHE1
por: Hu, Qian, et al.
Publicado: (2022) -
Immunoclassification characterized by CD8 and PD-L1 expression is associated with the clinical outcome of gastric cancer patients
por: Wang, Weili, et al.
Publicado: (2018) -
Designing herpes viruses as oncolytics
por: Peters, Cole, et al.
Publicado: (2015)